Product
TAK-580
Aliases
MLN2480
1 clinical trial
1 indication
Indication
MelanomaClinical trial
An Open-Label, Phase 1b, Multi-Arm Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Patients With Advanced MelanomaStatus: Terminated, Estimated PCD: 2018-05-11